Weiping Yuan
About
In The Last Decade
Weiping Yuan
29 papers receiving 263 citations
Peers
Comparison fields: 5 of 57
- Hepatology 126
- Molecular Biology 79
- Epidemiology 72
- Oncology 53
- Surgery 50
Countries citing papers authored by Weiping Yuan
This map shows the geographic impact of Weiping Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Yuan more than expected).
Fields of papers citing papers by Weiping Yuan
This network shows the impact of papers produced by Weiping Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Yuan. The network helps show where Weiping Yuan may publish in the future.
Co-authorship network of co-authors of Weiping Yuan
This figure shows the co-authorship network connecting the top 25 collaborators of Weiping Yuan. A scholar is included among the top collaborators of Weiping Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiping Yuan. Weiping Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 32 | |
| 8 | 2 | |
| 9 | Paraneoplastic Syndrome May be a Favorable Prognostic Factor in Patients with Hepatocellular Carcinoma Following Hepatectomy | 2 |
| 10 | 13 | |
| 11 | 7 | |
| 12 | 18 | |
| 13 | 2 | |
| 14 | 33 | |
| 15 | The diagnostic value of serum Golgi protein-73 in hepatocellular carcinoma | 1 |
| 16 | Prognostic Factors of Patients with Recurrent Hepatocellular Carcinoma after Re-excision | 1 |
| 17 | 25 | |
| 18 | 24 | |
| 19 | [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma]. | 5 |
| 20 | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.